Any documentation referred to in Regulation (EU) 2021/2282 and in this Regulation shall be sent in a digital format and shall be exchanged with and between the Coordination Group, the JSC Subgroup, the HTA Secretariat, the health technology developer and individual experts during joint scientific consultations on medicinal products through the HTA IT platform.
Art. 14 Regulation (EU) 2024/3169
Correspondence during joint scientific consultations
In forcesince 18 Dec 2024